•Widespreadunder-treatmentforthisagegroup.TargetOrgansaffectedbyHTN ••••HeartBrainKidneysRetina •CompellingReasonForInstitutingPharmacotherapy:MI,HF,CAD,DM,CRF,CVA.•••Pharmacologyandth
develop and/or sustain the process of vascular disease.6 Central to the inflammatory process is the family of cytokines or chemokines that are present at the site of inflammation or injury and directly induce vascular injury or attract cells that accelerate the atherosclerotic process.7–9 Measuremen...
However, it should be pointed out that the primary safety endpoint—a composite of major adverse events, including death, endstage renal disease, an embolic event resulting in end-organ damage, renal-artery or other vascular complica- tions, hypertensive crisis within 30 days or new renal-artery...